drugset / Trial / NCT01837927
Efficacy of NVA237 (50 μg o.d) Using Tiotropium (5μg μg o.d) as Active Control in COPD Patients.
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will assess the Efficacy of NVA237 (50 μg o.d) using tiotropium (5μg μg o.d) as active control in COPD patients.
Timeline
- Start
- 2014-04
- Primary completion
- 2016-04
- Completion
- 2016-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glycopyrrolate | Small molecule | 50 ug | Inhaled |
| Comparator | Tiotropium | Other / unclassified | 5 ug | Inhaled |